DexCom

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. 

CEO
Jacob S. Leach
CEOJacob S. Leach
Employees
11,100
Employees11,100
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1999
Founded1999
Employees
11,100
Employees11,100

DXCM Key Statistics

Market cap
28.11B
Market cap28.11B
Price-Earnings ratio
31.05
Price-Earnings ratio31.05
Dividend yield
Dividend yield
Average volume
5.80M
Average volume5.80M
High today
$75.44
High today$75.44
Low today
$71.50
Low today$71.50
Open price
$73.35
Open price$73.35
Volume
4.86M
Volume4.86M
52 Week high
$89.98
52 Week high$89.98
52 Week low
$54.11
52 Week low$54.11

Stock Snapshot

As of today, DexCom(DXCM) shares are valued at $71.50. The company's market cap stands at 28.11B, with a P/E ratio of 31.05.

As of 2026-06-06, DexCom(DXCM) stock has fluctuated between $71.50 and $75.44. The current price stands at $71.50, placing the stock +0.0% above today's low and -5.2% off the high.

The DexCom(DXCM)'s current trading volume is 4.86M, compared to an average daily volume of 5.8M.

In the last year, DexCom(DXCM) shares hit a 52-week high of $89.98 and a 52-week low of $54.11.

In the last year, DexCom(DXCM) shares hit a 52-week high of $89.98 and a 52-week low of $54.11.

DXCM News

TipRanks 17h
DexCom price target raised to $90 from $85 at Stifel

Stifel analyst Jonathan Block raised the firm’s price target on DexCom (DXCM) to $90 from $85 and keeps a Buy rating on the shares. The firm’s survey of 35 doct...

Barchart 18h
Is DexCom Stock Underperforming the Dow? - Barchart.com

...

Is DexCom Stock Underperforming the Dow? - Barchart.com
Nasdaq 2d
DexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026?

Key Points DexCom is a leading innovator in the continuous glucose monitoring market with a global footprint across 52 countries. Insulet dominates the tubele...

DexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026?

Analyst ratings

84%

of 31 ratings
Buy
83.9%
Hold
16.1%
Sell
0%

More DXCM News

TipRanks 2d
DexCom to present new clinical findings, advancements at ADA’s Sessions

DexCom (DXCM) will present new clinical findings, product advancements and strategic business initiatives reinforcing its commitment to improving care for peopl...

Simply Wall St 4d
Assessing Dexcom Valuation After FDA Software Defect Recall And Investor Reaction

The FDA enforcement report on a software defect in several Dexcom (DXCM) CGM iOS and watchOS apps has pushed product reliability and recall risk to the foregrou...

Assessing Dexcom Valuation After FDA Software Defect Recall And Investor Reaction
Simply Wall St 6d
How Investors May Respond To DexCom Global App Recalls Over Delayed Glucose Alerts

In April 2026, Dexcom voluntarily initiated Class II global recalls of its G7, ONE and ONE+ iOS and watchOS CGM apps after an FDA enforcement report highlighted...

How Investors May Respond To DexCom Global App Recalls Over Delayed Glucose Alerts

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.